Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC [Andover / United States of America]
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC [Andover / United States of America] located in ANDOVER MASSACHUSETTS, United States of America under the [Pfizer] organization had its last known inspection on 13 Oct 2023. There are 31 known inspections on record.
Site Details
Industries:
Biologics,
Human Drugs,
Medical Devices
Tags:
Biologics,
API Manufacturer,
Medical Devices,
FDF Manufacturer,
Human Drugs,
Generics,
Analytical Testing,
Biologics: HCT/P,
Vaccines,
Biologics Manufacturer,
Combination Product,
Medical Device Manufacturer,
Label,
Packaging,
Biologics API Manufacturer
Parent Organization:
Pfizer
Last Inspection Date:
13 Oct 2023
FEI:
1222181
Redica ID:
Investigators:
Stacey S Degarmo,
Michelle M Noe Varga,
Kathleen R Jones, PhD,
LCDR Debra Emerson,
Aimee Cunningham, PhD,
Priscilla M Pastrana,
Arie C Menachem,
Monique C Lo,
Christina Capacci Daniel, PhD,
Justine M Corson,
Ogechi C Nna,
Walter N Lange,
Yanming An, PhD,
Gene D Arcy,
Paula A Trost,
Christian D Lynch (CDL),
Ellen P Madigan,
Burnell M Henry,
Martha T Olone,
Victor J Gangi,
Brenda P King,
Prabhu P Raju,
Anissa M Cheung,
Nailing Zhang,
Christopher Downey, PhD,
Robert J Martin,
Joyce A Rockwell,
Megan A Haggerty,
Brentley S Collins,
Ekaterina Allen,
Wayne E Seifert,
Gunther Boekhoudt, PhD,
Jee Chung, PhD,
Kara A Scheibner, PhD,
Dawn M Braswell,
Sean R Marcsisin,
Amy Devlin, PhD,
Seth A Mailhot,
Maxwell Van Tassell, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Richard W Thornton,
Richard H Penta,
Julie D Bringger
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC [Andover / United States of America]'s Most Recent Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2023 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2023-09-19 |
| July, 2021 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2021-07-23 |
| May, 2019 | FDA 483 Response | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483R, 2019-05-20 |
| May, 2019 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2019-05-03 |
| May, 2019 | EIR | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - EIR, 2019-05-03 |
Experience Redica Systems’ NEW site dashboards and profiles
Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Loading...
Site Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more